Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
索拉非尼与经动脉化疗栓塞术治疗晚期肝细胞癌：一项成本效益分析
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-4308-7
Chen, Shuling; Peng, Zhenwei; Wei, Mengchao; Liu, Weifeng; Dai, Zihao; Wang, Haibo; Mei, Jie; Cheong, Mingfong; Zhang, Hanmei; Kuang, Ming
